Scandion Oncology enhances its external communication
Scandion Oncology, the Cancer Drug Resistance Company, today announced that Mads Kronborg, bringing more than a decade of corporate communication and investor relations experience in the global life-science industry, will now help plan and drive its external communication.Scandion Oncology, a biotech company developing first-in-class medicines aimed at treating cancer which has developed resistance against current treatment options, now strengthens its external communication capabilities. Effective today, Mads Kronborg, former Head of Corporate Communication and Media Relations at